Inventor · disambiguated record
Naohiro Washida
Also filed as: WASHIDA NAOHIRO
7 granted patents·5 pending applications·99 citations·filing 1994–2012
87Inventor score
Top patents by PatentIndex Score
12 records- 0188US7449185B2Antibodies to OCIF-binding moleculesDAIICHI SANKYO CO LTD·Filed 2004·Granted Nov 11, 2008·19 cites·57 claims
- 0286US7527790B2Methods of reducing bone absorption comprising administering an antibody that binds OBMDAIICHI SANKYO CO LTD·Filed 2002·Granted May 5, 2009·16 cites·43 claims
- 0384US7192718B2Methods for identifying a substance which specifically binds to an osteoclastogenesis inhibitory factor-binding molecule and modulates the biological activity thereofSANKYO CO·Filed 2003·Granted Mar 20, 2007·14 cites·18 claims
- 0467US2010136011A1Antibodies that bind to obmDAIICHI SANKYO CO LTD·Filed 2008·Application pending·0 cites
- 0563US6046033ABasic osteoblast growth factor II (bOGF-II)SNOW BRAND MILK PRODUCTS CO LTD·Filed 1995·Granted Apr 4, 2000·14 cites·5 claims
- 0660US5625039AAnti-human IgE monoclonal antibodiesSNOW BRAND MILK PRODUCTS CO LTD·Filed 1994·Granted Apr 29, 1997·19 cites·1 claims
- 0760US2012329671A1Methods of identifying obm modulatorsYAMAGUCHI KYOJI·Filed 2012·Application pending·0 cites
- 0860US2008187540A9Antibodies to OCIF-binding moleculesYAMAGUCHI KYOJI·Filed 2006·Application pending·0 cites
- 0958US2005208580A1Novel protein and method for producing the proteinYAMAGUCHI KYOJI·Filed 2005·Application pending·0 cites
- 1055US6693175B2Method for diagnosing bone dysbolismSANKYO CO·Filed 1998·Granted Feb 17, 2004·17 cites·72 claims
- 1136US2003092065A1Novel peptide and screening method by using the sameFiled 2002·Application pending·0 cites
- 1228US6998242B2Method of diagnosing metabolic bone diseasesSANKYO CO·Filed 2003·Granted Feb 14, 2006·0 cites·15 claims
Join the waitlist — get patent alerts
Get an alert when Naohiro Washida files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →